Concepedia

SM Opal

SO

1

Publications

356

Citations

1

H-Index

1994

Active since

Affiliations

Cleveland Clinic(Current)

SM Opal is an author at Cleveland Clinic.

Publications per year

1994–1994

1

Publications

1

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Fisher Cj, SM Opal, Pribble Jp et al. · PubMed · 1994 · 356 citations

Rows per page

1–1 of 1